BETA
Start SIP
Invest Now
Start SIP in BETA
Beta Drugs live price: ₹1062.1. It opened at ₹1,055 vs previous close ₹1,054; intraday high/low: ₹1,100/₹1,048. The 50 & 200 DMA stand at ₹1,353.17/₹1,598.89.
Beta Drugs Performance
- Low
- ₹1,048
- High
- ₹1,100
- 52 Week Low
- ₹990
- 52 Week High
- ₹2,000
- Open Price₹1,055
- Previous Close₹1,054
- Volume29,861
- 50 DMA₹1,353.17
- 100 DMA₹1,493.42
- 200 DMA₹1,598.89
Investment Returns
- Over 1 Month -27.11%
- Over 3 Month -36.46%
- Over 6 Month -43.65%
- Over 1 Year -30.49%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.9
- PEG Ratio
- -
- Market Cap Cr
- 1,072
- P/B Ratio
- 4.7
- Average True Range
- 73.11
- EPS
- 43.1
- Dividend Yield
- 0
- MACD Signal
- -113.81
- RSI
- 23.91
- MFI
- 11.4
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,062.10
+
8.3
(0.79%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹1,178.79
- 50 Day
- ₹1,353.17
- 100 Day
- ₹1,493.42
- 200 Day
- ₹1,598.89
Resistance and Support
1044.97
- R3 1,122.73
- R2 1,093.87
- R1 1,073.83
- S1 1,024.93
- S2 996.07
- S3 976.03
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2026-01-09 | Others | To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,062 As on 05 March, 2026 | 14:46
The Market Cap of Beta Drugs is ₹1072.1 Cr As on 05 March, 2026 | 14:46
The P/E ratio of Beta Drugs is 25.9 As on 05 March, 2026 | 14:46
The PB ratio of Beta Drugs is 4.7 As on 05 March, 2026 | 14:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.